P ercutaneous balloon mitral valvuloplasty has been performed increasingly often for the treatment of isolated mitral stenosis.1-7 However, the procedure involves puncture withl,2,8-l or without12 dilatation of the interatrial septum. Although this technique poses no practical problem if reasonable care is taken, it is associated with serious, albeit rare, complications. [3] [4] [5] [13] [14] [15] [16] [17] [18] In an effort to avoid transseptal catheterization, attempts using a purely arterial retrograde route have been reported but have met with limited use,1920 probably because of the technical difficulties encountered during retrograde left atrial catheterization when conventional19 or preshaped20 catheters are used. To overcome these difficulties, we have designed and developed a steerable catheter that easily and consistently enters the left atrium retrogradely via the left ventricle. 21 The encouraging preliminary results of retrograde nontransseptal balloon mitral valvuloplasty (RNBMV) with this steerable left atrial catheter have been re-diate and long-term results in 86 patients who underwent the procedure between April 1988 and July 1991 are presented.
Methods

Study Population
The new technique was attempted in 86 consecutive patients with symptomatic mitral stenosis (18 men and 68 women aged 51 + 11 years; range, 25-70 years). Three patients had previously undergone closed mitral commissurotomy. Two patients had suffered an embolic episode more than 8 months before their evaluation, but there was no evidence of left atrial thrombi. Fifty-five patients were in atrial fibrillation, and the remainder were in sinus rhythm. All patients in atrial fibrillation were anticoagulated for at least 2 months before valvuloplasty. Informed consent was obtained from all the patients before the procedure. Cardiac surgery standby was available in every instance.
The steerable left atrial catheter (Figure 1 ), developed in our center,2' 23 is a modification of standard guiding catheters (right Judkins or Ablatz) and accessories for coronary angioplasty (Advanced Cardiovascular Systems, Inc., Mountain View, Calif.; C.R. Bard, Ireland; Schneider-Shiley AG, European Division, Zurich, Switzerland the catheter may be confirmed either by the recording of left atrial pressures through the catheter or by the unobstructed movement of a J wire through the catheter lumen into the left atrial cavity ( Figure 2B ).
Difficulties may be encountered when the catheter tip is misplaced toward either the outflow tract of the ventricle or the free ventricular wall. In the former case, the catheter is advanced a short distance toward the apex and rotated slightly clockwise, and the curve is opened. In the latter, the catheter is rotated counterclockwise, and the curve is slightly tightened. Should these maneuvers meet with no success, the curve of the catheter tip is completely released, the catheter is moved toward the apex, and the procedure is repeated from the beginning. (In the latter case, the time needed to readjust the catheter tip is less than 2 minutes.) The steering was successful at the first attempt in approximately one quarter of the procedures and at the second or the third in most of the remainder; rarely were more than three attempts made. All the above manipulations were performed under fluoroscopy with the same predetermined projections as in the left ventriculography.
Once the catheter was in place, a 0.038-in. J guide wire 260 cm long was inserted into the left atrium and was stabilized either by forming spirals within the atrial cavity ( Figure 2C ) or by being introduced into a proximal branch of the pulmonary vein. The atrial catheter was then removed, and a pigtail catheter was introduced over the guide wire into the atrium. Atrial pressures were recorded, and a stiffer guide wire (0.038 in., 260 cm, J tip, heavy duty) was inserted into the atrium via the pigtail catheter and stabilized as above. The pigtail catheter was then removed. As a final check on the route of the guide wire, a flow-directed catheter was introduced over this wire to the left ventricle. The balloon was inflated in the outflow region of the ventricle with carbon dioxide or with a dilute dye solution and advanced toward the mitral valve (Figures 3A and 3B) . If this movement was unobstructed, it proved that the guide wire had passed correctly through the inflow tract of the ventricle and had not become involved with the subvalvular apparatus.
When the double balloon technique was used, the same maneuvers were repeated through the left femoral artery. The second left atrial catheterization was easier and faster than the first, because the fluoroscopic image of the first guide wire could be used as an aid in positioning the second steering system. The right femoral arterial sheath was then replaced with either a 14F sheath or an adjustable introducer (Medina-Schneider). Through this, the balloon catheter was introduced along the guide wire under fluoroscopy and positioned across the mitral valve. The balloon was then inflated by hand ( Figure 4 ) according to the standard steps. ,2,9-'2 Because the guide wire remains stabilized within the left atrium throughout the procedure, it is difficult for the balloon to slip from the mitral orifice during dilatation. In this event, however, the balloon tends to move along the guide wire into the atrium rather than back into the left ventricle. In the present study, we used various balloon sizes (Table 1) . In the first patients of our series, single balloons were used, because they were the only type available to us at that time. Our approach in these cases was conservative, and the balloon diameter was significantly smaller than the diameter of the mitral annulus; consequently, factors such as valve condition and age were neglected. A small balloon (23 or 25 mm) was used initially, and if the immediate result was assessed as suboptimal, redilatation was performed with a larger balloon (up to 30 mm). In four patients in whom a larger-diameter balloon was considered to be necessary, the bifemoral technique was used. Twin balloons were used when they became available to us. For patients later in the series, the choice of the twin balloon was based on criteria reported previously.26
The patients were kept in the coronary care unit, the sheaths were removed, and hemostasis was performed by compression. Most patients were discharged 24 hours after the procedure. If there were any arterial or other complications, the patients remained under observation; most were discharged 1 day later.
Echocardiographic Examination M-mode, two-dimensional, and Doppler echocardiography were performed before and 1 or 2 days after valvuloplasty in all patients and were repeated over the follow-up period. Transesophageal echocardiography was also performed in the last 42 patients.
Echocardiographic studies were focused particularly on 1) the presence of thrombi in the left atrium, 2) the determination of mitral valve area,27,28 3) the degree of mitral regurgitation, and 4) assessment of the morphological characteristics of the mitral valve and subvalvular structures by use of an echocardiographic score. 29 
Evaluation of Functional Capacity
Evaluation of functional capacity was based on the criteria of the New York Heart Association (NYHA)311 and on exercise duration and maximal oxygen consumption during cardiopulmonary exercise stress testing (Weber protocol).3'
Follow-up
The patients were routinely examined in the third, sixth, and 12th month after valvuloplasty and annually thereafter for functional capacity evaluation as above and the determination of mitral valve area by both Doppler and two-dimensional echocardiography. All patients who had been treated by valvuloplasty alone were examined in July 1991 for overall evaluation of their condition.
Statistical Analysis
Data are presented as mean ±1 SD. For comparisons between continuous variables before and after valvuloplasty, Student's paired t test and ANOVA for repeated measurements were used. The relation between hemodynamic and echocardiographic parameters was examined with linear regression analysis. To identify predictive factors for an increase in mitral regurgitation or in mitral valve area after RNBMV, stepwise regression analysis was performed on the following parameters: sex, age, NYHA class, cardiac rhythm, valve rigidity, valve thickening, valve calcification, subvalvular fibrosis, total echocardiographic score,29 cardiac output, mean pulmonary arterial pressure, mean left atrial pressure, mitral valve area, transmitral pressure gradient, effective balloon dilating area (EBDA), and the EBDA normalized to body surface area (EBDA/BSA).26 A value of p<0.05 was accepted as statistically significant. 
Complications
See Table 3 . Major complications such as cardiac perforation, cardiac tamponade, embolic events, or death were not encountered in our study population.
Mitral regurgitation. The degree of mitral regurgitation was unchanged or improved in 58 patients (68%) and increased by one grade in 21 patients (25%), by two grades in five patients (6%), and by three grades in one patient (1%). However, only three patients had mitral regurgitation of >2+ at the end of the procedure. The first of these underwent valve replacement immediately and the second 4 months later. The third did well under medical treatment.
The EBDA/BSA ratio (r=0.666, F=20.69, p<0.001), mitral valve leaflet rigidity (r=0.58, F=20.011, p<0.001), and mitral valve regurgitation before the procedure (r=0.458, F=21.255, p<0.001) were the most significant predictors for an increase in mitral regurgitation immediately after the procedure.
Bleeding and vascular complications. Bleeding requiring blood transfusion occurred in two patients (2.4%). Three patients (3.5%) showed hematoma in the region of the right femoral artery, which disappeared without any sequelae.
In two patients (2.4%), there was significant weakening of the arterial pulse in the leg. The first was successfully treated with balloon angioplasty of the right femoral artery, whereas the second, who had no functional problems, required no special treatment.
Arrhythmias and intraventricular conduction disturbances. Ventricular extrasystoles or salvos of nonsustained ventricular tachycardia were recorded in all patients during the procedure, and transient disturbances of atrioventricular conduction were noted in four. In no case was special treatment necessary. ECG disturbances of intraventricular conduction persisting for more than 24 hours were observed in five patients (2 days in two, 1 week in two, and 3 months in one patient). follow-up were 5.6+ 1.8, 9.9+2.6, and 12.8±2.4 minutes, respectively, and the maximum oxygen consumption increased from 9.1±2.2 to 14.1±3 and 17.1±2.6 ml/kg/ min, respectively. The increases in these two parameters were significant both over the first 3 months and after the third month.
Two-year follow-up. All of the first 26 consecutive patients who had undergone valvuloplasty 2 or more years before were reevaluated 3, 6, 12, and 24 months after the procedure.
The mitral valve area was 0.93±0.22 cm2 before valvuloplasty, increased to 2.06±0.4 cm' immediately after, and remained unchanged during the 2-year follow-up period (third month, 2.14+0.47; sixth month, 2.15+0.51; first year, 2.01+0.47; second year, 1.99±0.48 cm2; Figure 5 ). Four patients (15.4%) had restenosis, three with recurrence of symptoms.
In all 16 patients who had undergone cardiopulmonary exercise stress testing before the procedure, including three of the four with restenosis, the test was repeated at each follow-up during the 2-year period. The durations of the stress tests before valvuloplasty and at the 3, 6, 12, and 24-month follow-up were 5 .3+1.8, 10.1+2.4, 12.7+1.9, 13.9+2, and 13.7±2.6 minutes, respectively ( Figure 6 ). Figure 7 ). The main improvement in both these parameters occurred during the first and, to a lesser degree, the second trimesters. incidence of mitral regurgitation >2+ was relatively low in our series of patients (3.5%) compared with mitral valvuloplasty by the transseptal route1 13 and was exclusively related to torn mitral valve leaflets. The position of the guide wire within the left ventricle rules out the possibility of damage to the ventricular apex during insertion of the balloon catheter, because the catheter tip, constrained by the guide wire, never approaches this part of the heart at all closely.
Technical Skills
Mitral valvuloplasty is a procedure that demands ability and experience on the part of the operator, with the incidence of serious complications diminishing as the operator's experience grows. 13 The learning curve for RNBMV seems to be no different from that of the transseptal technique and may be even shorter. This assumption is supported by the fact that, despite its continuous refinement, the technique is performed by four different operators in our institution.
Financial Aspects
The cost of a mitral valvuloplasty procedure is determined by the cost of the materials, the duration of the procedure, and the hospital stay of the patient. Because the hospital stay is approximately the same with the RNBMV and transseptal techniques (most of our patients were discharged after 24 hours and almost all of the rest 1 day later), the first two factors are the most important. The time required for the retrograde procedure is shorter than for the transseptal technique.5 Furthermore, with RNBMV there is no need for a system to puncture and dilate the interatrial septum. The cost of the guiding catheter used in the retrograde technique has not yet been determined but is likely to be comparable to the cost of the system used to puncture the interatrial septum. Thus, the overall cost of the retrograde technique would seem to be less than the cost of the transseptal procedure.
Retrograde or Transseptal?
RNBMV compares favorably with the transseptal technique in terms of effectiveness, safety, and cost. Furthermore, it seems to be less technically demanding and has the advantage that it does not involve puncture of the interatrial septum. However, it does have the drawback of occasionally leading to arterial injury.
Further studies will show whether it may really be considered as an alternative method or method of choice for opening a stenotic mitral valve.
